OneMedNet Adds 2.7M Annual Cardiovascular Studies, Expanding Network

Core Insights - OneMedNet Corporation has expanded its Cardiovascular network by adding 85 new cardiovascular centers and data sources, positioning itself as one of the largest providers of Cardiovascular Real-World Data (RWD) [1][5] Industry Context - Cardiovascular diseases (CVDs) are the leading cause of death globally, responsible for approximately 19.8 million deaths in 2022, which accounts for about 32% of all global mortality [2] - The economic burden of CVD is significant, driving an estimated $320 billion annually in the United States and over $1 trillion globally in direct healthcare costs and lost productivity [2] Company Positioning - The enriched multimodal cardiovascular data network of OneMedNet is well-suited for the pharmaceutical and insurance sectors, providing real-time data that offers deeper insights into disease progression, treatment responses, and outcomes [3] - The expansion enhances OneMedNet's ability to deliver de-identified cardiovascular imaging, diagnostic reports, and electrocardiograms (ECG) at an unprecedented scale, continually updated to reflect the latest clinical insights [4][6] - OneMedNet is positioned as the premier source for high-quality, regulatory-grade cardiovascular RWD, which fuels innovation, supports clinical evidence generation, and improves patient outcomes [5] Technological Advancements - By combining de-identified cardiovascular imaging, structured reports, and ECG signals, OneMedNet provides real-world clinical insights that accelerate innovation in diagnostics, therapeutics, and AI model development [6] - The company utilizes its iRWD™ platform to harness the potential of over 1,750 healthcare sites, delivering precision insights across various medical fields, including cardiology [7]